Drug policy reform advocates pen letter-to-the-editor to Journal of the American Medical Association (JAMA) encouraging them to not confuse specific cannabinoid research with whole cannabis products in general as an effective and safe medicinal therapeutic.
Brian imaging research published this month in the journal Molecular Psychiatry provides physiological evidence as to why cannabis may mitigate certain symptoms of post-traumatic stress disorder (PTSD)
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To have NORML’s media advisories and legislative updates delivered straight to your in-box, sign up for ‘NORML News’ here.]
Cannabis inhalation and the administration of cannabinoids are both associated with Ã¢â‚¬Å“significant analgesic effectsÃ¢â‚¬Â in the treatment of chronic non-cancer pain, according […]
NORML has recently posted online the fourth edition of its popular and comprehensive booklet, “Emerging Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature.”
Updated and revised for 2011, this report reviews approximately 200 newly published scientific studies assessing the safety and efficacy of marijuana and its compounds in the treatment […]